Cat. No.: DIA-0230179
Product Information | |
---|---|
CAS No. | 275371-94-3 |
Synonyms | ITM077, R1583, BIM51077 |
Formula | C152H232N40O45 |
Molecular Weight | 3339.71 |
Target | Glucagon-like peptide 1 (GLP-1) receptor |
Product Description | Taspoglutide is a long-acting glucagon-like peptide 1 (GLP-1) receptor agonist developed for treatment of type 2 diabetes, with an EC50 value of 0.06 nM. |
Format & Storage | |
---|---|
Format | Solid |
Purity | > 98% |
Shipping | Shipped on dry ice. |
Storage | Protect from light Powder: -80 °C, 2 years; -20 °C, 1 year *In solvent: -80 °C, 6 months; -20 °C, 1 month (protect from light) |
Solubility Overview | Soluble in DMSO |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.